Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Avigan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Hepatology (Baltimore, Md.)|December 17, 2008
Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 casesAllen D Brinker, Ronald T Wassel, Jenna Lyndly, et al.
Drug Safety|October 26, 2021
Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case SeriesSamantha Cotter, Jennie Wong, Neha Gada, et al.
Drug Safety|August 5, 2025
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI InitiativeMelissa Palmer, Daniel Seekins, Mark Avigan, et al.
Current Protocols|July 5, 2022
Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver-Chip for the Study of Drug-Induced Liver InjuryQiang Shi, Ayesha Arefin, Lijun Ren, et al.
Digestive Diseases and Sciences|February 28, 2024
Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical PresentationsAlexander Pop, Dina Halegoua-DeMarzio, Huiman Barnhart, et al.
ALTEX|February 19, 2014
Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-actionCatherine Willett, Jessica Caverly Rae, Katy O Goyak, et al.
JAMA Dermatology|March 16, 2017
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working GroupEmanual Maverakis, Elizabeth A Wang, Kanade Shinkai, et al.
Clinical Pharmacology and Therapeutics|November 7, 2017
Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal NecrolysisTeri A Manolio, Carolyn M Hutter, Mark Avigan, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Hepatology (Baltimore, Md.)|December 17, 2008
Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 casesAllen D Brinker, Ronald T Wassel, Jenna Lyndly, et al.
Drug Safety|October 26, 2021
Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case SeriesSamantha Cotter, Jennie Wong, Neha Gada, et al.
Drug Safety|August 5, 2025
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI InitiativeMelissa Palmer, Daniel Seekins, Mark Avigan, et al.
Current Protocols|July 5, 2022
Co-Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver-Chip for the Study of Drug-Induced Liver InjuryQiang Shi, Ayesha Arefin, Lijun Ren, et al.
Digestive Diseases and Sciences|February 28, 2024
Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical PresentationsAlexander Pop, Dina Halegoua-DeMarzio, Huiman Barnhart, et al.
ALTEX|February 19, 2014
Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-actionCatherine Willett, Jessica Caverly Rae, Katy O Goyak, et al.
JAMA Dermatology|March 16, 2017
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working GroupEmanual Maverakis, Elizabeth A Wang, Kanade Shinkai, et al.
Clinical Pharmacology and Therapeutics|November 7, 2017
Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal NecrolysisTeri A Manolio, Carolyn M Hutter, Mark Avigan, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
Pageof 3